1. American Medical Association Council on Drugs 1970, “Statement regarding the University Group Diabetes Program (UGDP) study, November 2, 1970,” Diabetes 19(2): vi–vii.
2. Philip K. Bondy 1966, “Therapeutic considerations in Diabetes Mellitus,” in Controversy in Internal Medicine, ed Ingelfinger et al. (Philadelphia: W.B. Saunders Co.), 499–503.
3. Allan M Brandt 2006, The Cigarette Century (New York: Basic Books).
4. Daniel P. Carpenter 2010, Reputation and Power: Organization Image and Pharmaceutical Regulation at the FDA (Princeton: Princeton University Press).
5. Thomas Chalmers 1975, “Settling the UGDP controversy,” Journal of the American Medical Association 213 (6): 624.